Hope: Psoriasis and Psoriatic Arthritis Treatments in Clinical Trials

While treatments for psoriasis and psoriatic arthritis are expanding, many people continue to need additional options.

What follows is information on the dozens of experimental treatments in development by the pharmaceutical and biotech industries, specifically for psoriasis and psoriatic arthritis.

Many of these will never make it to market, but many of them WILL. Perhaps one of these will help you or one of your loved ones someday.

(Note: We have not included the dozens of treatments being studied for rheumatoid arthritis, even though some of them will almost certainly end up helping psoriasis and/or psoriatic arthritis patients as well.)

If you think you may want to participate in a clinical trial, visit the U.S. Government's clinical trials website for psoriasis and psoriatic arthritis.

Be hopeful!

III

Phase III

Phase Three clinical trials are advanced trials for drugs that could come to market in anywhere from a few months to a couple years, if the results for safety and effectiveness pan out. These are the drugs closest to market. An estimated 70% to 90% of drugs will succeed in Phase Three trials and reach patients.

II

Phase II

Phase Two clinical trials have passed an initial screening in human subjects, and based on that limited data, appear safe. Scientists also typically have some theory at this stage for why a particular compound may help a particular disease. Phase Two studies test a drug for effectiveness. These drugs are typically 3-5 years away from market, provided the Phase Two and later Phase Three trials prove successful. About one-third of drugs that enter Phase One studies proceed successfully through both Phase One and Phase Two trials.

I

Phase I

Phase One clinical trials are early stage trials that examine different dosage levels in a small number of healthy human volunteers, focused on safety. These drugs are many years from market, and many will not make it to market, although roughly 70% of these drugs will proceed to Phase Two trials. Prior to Phase One testing, drugs are tested in cells in test tubes and in animals.

O

Other Potential Treatments

This is where we post other noteworthy items, not currently in Phase One, Two or Three trials but still worth keeping an eye on.